Company Legal Name
Latest Valuation
Founded Year
Headquarter
Medable Inc. develops software platforms that enable pharmaceutical companies and research organizations to conduct decentralized and hybrid clinical trials through remote patient monitoring capabilities. Founded in 2015 and headquartered in Palo Alto, the company addresses the growing demand for flexible trial methodologies that reduce patient burden while maintaining data integrity and regulatory compliance. Medable's platform facilitates virtual patient engagement, real-world evidence collection, and streamlined trial operations across multiple therapeutic areas. The company serves biopharmaceutical companies, contract research organizations, and academic medical centers seeking to modernize their clinical research processes and improve patient accessibility to trials through digital-first approaches.
Revenue & Revenue Growth Share
Revenue
Revenue Growth
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.
